BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 29254484)

  • 21. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
    Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
    Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoproteins, lipids and risk of cancer.
    Borgquist S; Butt T; Almgren P; Shiffman D; Stocks T; Orho-Melander M; Manjer J; Melander O
    Int J Cancer; 2016 Jun; 138(11):2648-56. PubMed ID: 26804063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
    Holmes MV; Millwood IY; Kartsonaki C; Hill MR; Bennett DA; Boxall R; Guo Y; Xu X; Bian Z; Hu R; Walters RG; Chen J; Ala-Korpela M; Parish S; Clarke RJ; Peto R; Collins R; Li L; Chen Z;
    J Am Coll Cardiol; 2018 Feb; 71(6):620-632. PubMed ID: 29420958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United States collaborative study on cardiovascular epidemiology).
    Rywik SL; Manolio TA; Pajak A; Piotrowski W; Davis CE; Broda GB; Kawalec E
    Am J Cardiol; 1999 Sep; 84(5):540-8. PubMed ID: 10482152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
    Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
    Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
    Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
    Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality.
    Sung KC; Ryu S; Wild SH; Byrne CD
    Heart; 2015 Apr; 101(7):553-8. PubMed ID: 25637367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk of cardiovascular death in relation to blood lipid composition in male inhabitants of Tyumen: results of a 12-year prospective study].
    Akimova EV; Gakova EI; Pushkarev GS; Smaznov VIu; Kaiumova MM; Gafarov VV; Kuznetsov VA
    Ter Arkh; 2012; 84(9):41-6. PubMed ID: 23091852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study.
    Ivert T; Malmström H; Hammar N; Carlsson AC; Wändell PE; Holzmann MJ; Jungner I; Ärnlöv J; Walldius G
    PLoS One; 2018; 13(8):e0201972. PubMed ID: 30138379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
    Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
    Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
    Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
    Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
    Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
    Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
    His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
    Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of assessment techniques: plasma lipid and lipoproteins related to the metabolic syndrome.
    Davy BM; Davy KP
    Lipids Health Dis; 2006 Jan; 5():3. PubMed ID: 16448573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.